Search

everythinglearnresearchcommunity

for

Search:↓

Skin cells and immune cells change in a skin condition called hidradenitis suppurativa, and a certain treatment can improve these changes.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Ptch2 plays a key role in controlling stem cell function and the ability to regenerate after birth.

Toll-like receptor 3 helps repair the skin barrier after UV damage.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Truncated LTBP-1 disrupts TGF-beta signaling, affecting hair growth.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Loss of Pten in certain hair follicle stem cells increases skin cancer risk.

Thyroid hormone (T3) may reverse gray hair by stimulating hair growth.

LL-37 helps stem cells grow and move, aiding tissue regeneration and hair growth.

Adding TERT and BMI1 to certain skin cells can improve their ability to create hair follicles in mice.

Innate lymphoid cells type 1 may contribute to alopecia areata.

The CD4 protein may play a role in the behavior of certain skin cells, affecting their growth, movement, and differentiation.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Bone marrow-derived cells can lead to skin inflammation and tumors in mice.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Targeting thyroid hormone receptor α in liver cells may help treat liver fibrosis.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

IL-1 signaling is crucial for hair follicle stem cell growth and wound healing.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Blocking certain proteins on immune cells may help treat alopecia areata.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

ITK inhibitors may effectively treat alopecia areata.

TGF-β2 plays a key role in human hair growth and development.

Activating TRPV1 can boost hair growth by involving neurons, macrophages, and fibroblasts.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Thy-1 protein helps improve blood flow and wound healing in the skin.